Comprehensive research guide to curcumin — covering NF-κB and COX-2 inhibition mechanisms, the bioavailability problem and solutions (BCM-95, Longvida, Meriva, piperine), dosing protocols, and anti-inflammatory research.

A research overview of bioavailability enhancement strategies for supplements and compounds — covering piperine/BioPerine, liposomal delivery, SLCP nanocurcumin, cyclodextrin complexes, and timing protocols.

Comprehensive resveratrol research guide covering SIRT1 activation, trans vs cis isomers, bioavailability challenges, micronized and liposomal forms, 150-500mg dosing protocols, and the NMN+resveratrol combination rationale from longevity research.

Research comparison of IV NAD+, NMN, NR, and sublingual routes — covering bioavailability, PARP enzyme substrate, sirtuin activation, mitochondrial biogenesis, IV flush effects, and typical clinical protocols from 500–1500mg.

An in-depth research review of quercetin as a senolytic, anti-inflammatory, and mast cell stabilizer — including bioavailability solutions, the dasatinib+quercetin protocol, and comparison with fisetin.

Complete research guide to fisetin as a senolytic agent — flavonoid mechanism, comparison with dasatinib/quercetin, 20 mg/kg pulsed research dosing, 500–1500 mg human protocols, 2-day pulse timing, bioavailability challenges, and liposomal fisetin.

Complete comparison of BPC-157 oral vs injectable administration — systemic vs local effects, gut healing research, musculoskeletal applications, bioavailability data, stable gastric pentadecapeptide properties, and dose equivalence considerations.

An authoritative breakdown of peptide versus small molecule differences: bioavailability, receptor specificity, metabolism, half-life, and administration routes.

Why most research peptides require injection, SubQ bioavailability data, intranasal BBB crossers, and oral peptides like BPC-157 and semaglutide explained.